THE Pharmacy Guild of Australia has warned members of significant Jun price drops for three medications due to the price disclosure measures of the government's Pharmaceutical Benefits Scheme reforms.
The impacted drugs are Lipidil (fenofibrate) 48mg and 145mg, as well as Aubagio (teriflunomide).
An update from the Guild yesterday urged pharmacies to keep an eye on its website for changes expected to be released by the Department of Health later this month.
Wholesalers should also be contacted to help manage stock levels carefully in the lead up to the expected changes, the Guild said.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 May 19
